What is a microdose? Consumers dabbling in psychedelics have long believed that taking a tenth to a fifth of a recreational ...

Novo Nordisk NOVO B announced plans on Oct. 9 to acquire Akero Therapeutics and its phase 3 FGF21 analog efruxifermin for USD 4.7 billion upfront and a potential additional USD 500 million contingent ...

(RTTNews) - Novo Nordisk has entered into a definitive agreement to acquire Akero Therapeutics, Inc., a publicly held clinicalstage company developing treatments for patients with serious metabolic ...

Despite the difficulties Novo Nordisk's GLP-1 franchise has encountered due to Eli Lilly and manufacturers of compounded versions of semaglutide, demand for Wegovy remains strong. So, its sales ...

IN recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave the world Ozempic, lost a quarter of its market value in a day after it cut ...

Novo Nordisk A/S (NYSE:NVO) is among the best safe stocks to buy now. Park Avenue Securities LLC acquired a new stake in Novo Nordisk A/S (NYSE:NVO) through the purchase of 85,970 shares of the ...

Because of its size, the drugmaker has an outsize effect on the country. Now, as it sheds jobs, forecasts for Denmark’s growth are falling, too. By Eshe Nelson The success of Novo Nordisk, the ...

Two years ago, Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company, was performing so well that it was positively affecting the economy of its home country. However, the past 18 months ...

Novo Nordisk has recently encountered headwinds in its core therapeutic area. The company has implemented changes that could pay off in the long run. Novo Nordisk's shares look reasonably valued. With ...

For patients hoping to avoid needles, a pill form of the blockbuster weight-loss drug Wegovy may soon be an option. Novo Nordisk said in a press release that people who took the daily pill in a ...